2167 Microsatellite status predicts BRAF V600E and KRAS exon 2 mutations prognostic value in stage III colon cancers (CC) patients treated with adjuvant FOLFOX +/- cetuximab. A post-hoc analysis of the PETACC8 trial. (September 2015)

Record Type:: Journal Article
Title:: 2167 Microsatellite status predicts BRAF V600E and KRAS exon 2 mutations prognostic value in stage III colon cancers (CC) patients treated with adjuvant FOLFOX +/- cetuximab. A post-hoc analysis of the PETACC8 trial. (September 2015)
Main Title:: 2167 Microsatellite status predicts BRAF V600E and KRAS exon 2 mutations prognostic value in stage III colon cancers (CC) patients treated with adjuvant FOLFOX +/- cetuximab. A post-hoc analysis of the PETACC8 trial
Authors:: Taieb, J.
Zaanan, A.
Malicot, K. Le
Julie, C.
Blons, H.
Mineur, L.
Tabernero, J.
Mini, E.
Folprecht, G.
Laethem, J.L. Van
Lepage, C.
Emile, J.F.
Laurent-Puig, P.
Abstract:
Is Part Of:: European journal of cancer. Volume 51:(2015)Supplement 3
Journal:: European journal of cancer
Issue:: Volume 51:(2015)Supplement 3
Issue Display:: Volume 51, Issue 3 (2015)
Year:: 2015
Volume:: 51
Issue:: 3
Issue Sort Value:: 2015-0051-0003-0000
Page Start:: S389
Page End:
Publication Date:: 2015-09
Subjects:: Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:: http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0959-8049(16)31087-5 ↗
Languages:: English
ISSNs:: 0959-8049
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 2025.xml